Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US price war continues to plague Nycomed:

This article was originally published in Clinica

Executive Summary

The profits warning issued by Nycomed in June (see Clinica No 712, p 11) has been borne out by the Norwegian company's six- month results. Price pressure in the US contrast media market caused profits at Nycomed Imaging to fall 16.7% to NKr 1,012 million ($156 million) in the half-year ended June 30th. Sales were down 5.3% to NKr 2,444 million. Combined sales of Omnipaque, Imagopaque and Visipaque in all markets outside North America increased 13% compared with the 1995 period.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT088744

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel